Villarin, Romeo .
HRN: 26-35-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
RIFAXIMIN 200MG (TAB)
12/12/2024
12/19/2024
PO
200mg
Tid
T/c Hepatic Enceph
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes